Clinical Trial Update: Macugen (Pegaptanib Sodium) Alone, Versus Macugen in Combination With PDT (Photodynamic Therapy) With Visudyne (Verteporfin) in Patients With Age-Related Macular Degeneration (AMD) [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating Macugen alone versus Macugen plus PDT with Visudyne in age-related macular degeneration was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Age-related Macular Degeneration

Drugs mentioned

• Macugen (pegaptanib sodium)
• Visudyne (verteporfin)

Snippet

Sponsor: Eyetech Pharmaceuticals | Conditions: Age-Related Macular Degeneration | Phase 4 | Status: TERMINATED